Figure 7.
Antitumor efficacy of intraperitoneal Triogel based on whole-body bioluminescence imaging in an ES-2-luc ovarian tumor model (Reproduced with permission from reference 68).
Antitumor efficacy of intraperitoneal Triogel based on whole-body bioluminescence imaging in an ES-2-luc ovarian tumor model (Reproduced with permission from reference 68).